Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sidas is a French company focused on foot comfort, foot health, and performance products spanning sports, medical, wellness, and everyday-use markets. The company develops and sells insoles, socks, foot protection products, sandals, bootfitting tools, analysis tools, and thermoforming systems, and it also operates in medical and podiatry-related segments through the Podiatech brand. Founded in 1975, Sidas originated in ski boot comfort and expanded into broader foot biomechanics, orthotics, and wellbeing solutions. Its business is primarily device- and product-based rather than drug-based, with commercialized offerings sold directly and through retail, professional, and corporate channels in many countries. For a biotech analyst, Sidas is best understood as a foot-health/orthotics and performance-wellness company rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sidas.